Boston Financial & Equity started off 2020 by closing a lease transaction with a Seattle-based drug discovery company for a $725,000 fermentation system.

The company founded in 2011, originally funded by family and friends, has raised over $29 million to date.

Its approach to drug discovery accelerates the timeline and increases manufacturing efficiencies, reducing the costs to the biopharmaceutical industry.

Although the company has less than a year of cash and minimal revenues, it has agreements with three of the largest pharma companies.